Browse regulations

FDA mandates approved Medication Guides for outpatient prescription drugs posing serious public health concerns, requiring specific content, format, and distribution through manufacturers to dispensers to patients.

Imposes high compliance costs on industry, duplicates market-provided information, creates federal overreach, leads to warning fatigue, and burdens small businesses; alternatives like pharmacist counseling and manufacturer leaflets achieve patient safety more efficiently.

21 CFR Part 99 governs how drug and device manufacturers may disseminate information about unapproved (off-label) uses to healthcare professionals and other covered entities. It creates a regulatory safe harbor requiring advance FDA submission, peer-reviewed sources only, prominent disclaimers, balanced bibliography, and potentially additional FDA-mandated information. The rule allows dissemination but under strict FDA oversight to prevent false or misleading information and protect public health.

This regulation imposes prior restraint on commercial speech and scientific exchange, forcing manufacturers to seek FDA permission before sharing peer-reviewed research with doctors. Compliance costs create barriers to entry favoring large incumbents, while the 60-day review period and threat of required additional disclosures chill innovation and delay potential therapeutic advances. The unseen harm includes suppressed information about off-label benefits, reduced competitive pressure, and unconstitutional expansion of agency power over truthful scientific communication—all violations of limited government and free enterprise principles.

FDA regulation requiring applicants for drug/device marketing approval to disclose financial interests (equity, royalties, patents, payments >$25k) of clinical investigators in covered studies to assess potential bias in study data. Requires certification or disclosure statements on FDA forms, with record retention for 2 years post-approval.

Americans would be worse off without this because financial conflicts of interest in clinical trials directly threaten the reliability of data used to approve drugs and medical devices. Unreliable data means unsafe or ineffective products reach the market, endangering patients and wasting healthcare resources. The regulation achieves its outcome through a targeted, proportional disclosure system that allows FDA to evaluate bias risk and take corrective action when needed—a mechanism that would be difficult to replicate without mandatory transparency. While compliance entails costs, these are dwarfed by the catastrophic costs of compromised medical evidence.

This regulation implements the 1998 US-EU Mutual Recognition Agreement for pharmaceutical GMP inspections and medical device conformity assessments. It establishes procedures for mutual acceptance of inspection reports, determines equivalence of regulatory systems, creates joint committees, and sets up an alert system for quality defects. The 3-year transition period involves confidence-building activities, joint training, and inspection cooperation between FDA and European authorities.

This represents regulatory extraterritorialism that burdens US businesses with compliance costs for European standards through the backdoor of 'equivalence.' It creates a permanent bureaucratic apparatus (Joint Sectoral Committee, ongoing monitoring, mandatory information exchanges) that will inevitably expand. The 'equivalence' determinations are inherently political and will result in regulatory harmonization toward the more restrictive standards, raising US requirements over time. Mutual recognition sounds efficient but actually entrenches a transnational regulatory regime that undermines US sovereignty and imposes hidden costs on manufacturers who must satisfy two masters rather than one. The 3-year transition is a foot-in-the-door for permanent supranational oversight of American production facilities.

This regulation (19 CFR Part 191) governs drawback claims—refunds of customs duties, fees, and taxes on imported merchandise when that merchandise or products made from it are exported or destroyed. It covers pre-2016 claims under 19 U.S.C. 1313, including definitions, eligibility, filing procedures, manufacturing rulings (general and specific), recordkeeping requirements, and substition rules. The part explicitly states claims may not be filed after February 23, 2019; new claims go to Part 190.

This entire part is functionally obsolete: it applies only to drawback claims that cannot be filed after February 23, 2019. Maintaining it imposes unnecessary compliance burdens on any remaining legacy cases and clutters the Code of Federal Regulations with dead letter. Even while active, the underlying drawback program was a distortionary export subsidy violating neutral taxation principles, inviting regulatory capture, and imposing complex paperwork requirements that disproportionately harmed small businesses unable to navigate the bureaucratic rulings and schedules.

This regulation mandates extensive recordkeeping requirements for importers, exporters, customs brokers, and other parties involved in international trade. It defines 'records' broadly to include all business documents, electronic data, and technical information related to imports/exports, requires retention for 5 years (with some exceptions), allows alternative storage with prior notification, grants CBP expansive powers to examine records and issue summons, and imposes severe penalties ($100k or 75% of merchandise value for willful violations; $10k or 40% for negligence).

The compliance burden is enormous and hidden—costs dwarf the benefits. The regulation captures vast amounts of irrelevant data through its overbroad 'records' definition, imposes a rigid 5-year retention mandate that creates massive storage costs, and grants CBP warrantless fishing expedition powers. Small businesses bear a disproportionate 30% higher per-employee burden, raising barriers to entry and protecting large incumbents. The draconian penalties ($100k or 75% of value) can destroy small importers/exporters for minor administrative lapses unrelated to fraud. The unseen consequences include reduced international trade, higher consumer prices, compliance industry proliferation, and constitutional concerns under the Fourth Amendment. CBP can achieve legitimate revenue collection through targeted subpoenas with judicial oversight, not universal mandates that treat all traders as suspects. Private businesses are better positioned to determine appropriate document retention policies suited to their operations.

Federal regulation establishing safety standards for bicycle helmets, including testing requirements for impact protection, retention systems, peripheral vision, and labeling to reduce head injury risk

Imposes significant compliance costs on manufacturers while creating barriers to entry that protect established helmet makers from competition. The extensive testing requirements and documentation burden disproportionately harms small businesses. Most critically, it interferes with individual liberty and parental choice - adults should be free to assess their own risk/reward calculations regarding helmet use. The regulation also represents federal overreach into what is fundamentally a state/local matter of personal safety and commerce.

These regulations govern the use of NOAA's Data Collection Systems (DCS), including GOES and Argos, establishing procedural, technical, and informational requirements for system use, authorization criteria, and operational priorities for environmental data collection from government and non-profit users.

This regulation creates a government monopoly on environmental data collection services, distorting market competition and raising costs for users. It imposes unnecessary bureaucratic barriers, limits innovation by restricting commercial alternatives, and violates free enterprise principles by forcing users to seek government permission for data collection that could be provided more efficiently by private sector solutions.

This regulation governs Public Charter air transportation, establishing rules for charter operators, financial security requirements, contract terms, and consumer protections for one-way or round-trip charter flights arranged between operators and direct air carriers.

This regulation creates unnecessary federal bureaucracy over charter air transportation that could be handled by market forces and state-level consumer protection laws. The extensive financial security requirements, contract specifications, and regulatory oversight impose compliance costs that ultimately increase prices for consumers while providing minimal additional safety beyond existing aviation regulations. Small charter operators are disproportionately burdened by these requirements, reducing competition and limiting consumer choice in the charter air transportation market.

This regulation requires covered airlines to collect passenger names and emergency contact information for U.S. citizens on flights to/from the United States, maintain this data, and transmit it to government agencies within 3 hours of any aviation disaster to facilitate family notification and disaster response.

Creates a massive government database of American travelers' personal information with minimal security safeguards, violating privacy rights and creating security vulnerabilities. The regulation's costs - including compliance burdens on airlines, privacy invasions, and data breach risks - far outweigh its marginal benefit, as airlines already have passenger manifests and disaster response systems can function without this government-mandated surveillance infrastructure.

This regulation governs charter flights and charter passenger/cargo operations in interstate and foreign air transportation by U.S. certificated air carriers and foreign air carriers, establishing requirements for charter types, contracts, escrow/bond requirements, and authorization procedures.

This regulation creates a complex regulatory framework that imposes significant compliance costs on air carriers and charter operators, restricts market entry through licensing requirements, and establishes bureaucratic authorization processes that distort competition. The regulatory burden falls disproportionately on small operators while protecting established carriers through artificial barriers. Charter markets function effectively through private contracts and market mechanisms without federal oversight, and the regulation's cost-benefit ratio is unfavorable given the availability of state-level consumer protection laws.

This regulation establishes a federal aviation insurance program administered by the FAA. It provides both premium policies (where operators pay) and non-premium 'standby' policies (where the government indemnifies losses) for aircraft operations that: (1) are determined by the President to be necessary for US foreign policy, (2) operate in specific domestic/international contexts, and (3) cannot obtain commercial insurance on 'reasonable terms.' The program requires applications, evidence of commercial unavailability, various notifications, and binder fees. It covers hull, liability, personnel, baggage, and cargo risks.

This government insurance program creates severe market distortions and exposes taxpayers to unlimited liability. The 'reasonable terms' standard allows the FAA to undercut private insurers, creating moral hazard and mispricing risk. Non-premium policies particularly burden taxpayers with covering losses from private operations, while administrative requirements add compliance costs. If commercial insurers refuse coverage, that price signal correctly reflects unacceptably high risk—government should not override it. The foreign policy rationale provides insufficient justification for undermining free-market price discovery, encouraging reckless operations, and potentially bailing out private actors at public expense. Even limited programs invite mission creep and regulatory capture.

The HUBZone program provides federal contracting preferences to small businesses located in designated 'historically underutilized business zones.' To qualify, businesses must have their principal office in a HUBZone and ensure at least 35% of employees reside there. The program creates set-asides and evaluation preferences in federal contracting, administered by the SBA, covering qualified census tracts, non-metropolitan counties, Indian reservations, base closure areas, disaster areas, and governor-designated areas.

This regulation imposes significant compliance costs while distorting federal procurement away from merit-based competition. It substitutes government favoritism for free market allocation, incentivizes businesses to game geographic requirements rather than improve quality, and imposes a hidden tax on all taxpayers to benefit politically connected firms. The program's economic development objectives are better achieved through market forces and state/local initiatives without federal intervention.

The 8(a) Business Development program provides federal contracting assistance to socially and economically disadvantaged small businesses through a 9-year term with special extensions for pandemic-affected firms, including specific provisions for Native American groups, ownership requirements, and eligibility criteria based on social/economic disadvantage.

This program creates costly racial and ethnic preferences in federal contracting that distort market competition, increase government procurement costs, and violate constitutional equal protection principles while creating bureaucratic overhead and compliance burdens for all businesses.

Regulation governing standby letters of credit issued by Federal Home Loan Banks on behalf of member institutions and housing associates. It defines terms, authorizes issuance for four purposes (residential housing finance, community lending, asset/liability management, liquidity), requires full collateralization, sets eligible collateral rules (including government obligations for housing/community purposes), mandates reimbursement obligations, and imposes procedural requirements like expiration dates and transfer restrictions.

This is unnecessary micro-management of a specialized banking instrument. The Federal Home Loan Banks are sophisticated financial institutions that should be free to structure their own credit products without regulatory dictates about collateral types, purposes, and procedures. The 'community lending' and 'residential housing finance' mandates reflect social engineering goals, distorting market allocation of credit. Full collateralization requirements eliminate the risk-sharing that would naturally discipline both issuers and applicants. Each requirement—pre-approved transfers, specific expiration dates, mandatory government obligation collateral for certain purposes—increases compliance costs for already-regulated institutions while substituting bureaucratic judgment for market-based risk assessment. Private parties can negotiate terms appropriate to their risk appetite without the government mandating a one-size-fits-all framework.